We mainly examined overall mortality and the risks of shock, septic shock, cardiogenic shock, hypovolemic shock, heart failure, and pulmonary edema in patients with sepsis with hypoalbuminemia following albumin supplementation. This evidence concerns the gene ALB and Hypoalbuminemia.